# Calibrate **Source:** https://geo.sig.ai/brands/calibrate-health **Vertical:** HealthTech **Subcategory:** Metabolic Health Platform **Tier:** Emerging **Website:** joincalibrate.com **Last Updated:** 2026-04-14 ## Summary Metabolic health company delivering one-year GLP-1 programs with semaglutide or tirzepatide plus behavioral coaching, nutrition, and activity guidance via physician-supervised telehealth. ## Company Overview Calibrate is a metabolic health company that delivers a one-year weight loss program combining GLP-1 receptor agonist medications — including semaglutide and tirzepatide — with behavioral coaching, food education, sleep guidance, and activity programming through a telehealth platform. The program's clinical foundation differentiates it from consumer weight loss apps and traditional diet programs by centering medication management under physician supervision as the primary intervention, with lifestyle coaching structured to support long-term habit change alongside pharmaceutical treatment. Calibrate's approach reflects the clinical consensus that obesity is a chronic metabolic disease requiring medical treatment rather than a lifestyle choice addressable through willpower alone. The platform pairs each member with a dedicated health coach and a prescribing physician who manages medication titration, monitors metabolic labs, and adjusts the treatment protocol based on individual response. Members interact with their care team through the Calibrate app, which also delivers curriculum on nutrition, exercise, sleep, and emotional health across the program year. The structured one-year commitment is designed to establish durable behavioral patterns during the period when GLP-1 medications are suppressing appetite, giving members the window needed to rebuild their relationship with food and physical activity. Calibrate operates in the direct-to-consumer telehealth market and accepts insurance for physician services while navigating coverage variability for GLP-1 medications across different health plans. The company targets adults with obesity or weight-related metabolic conditions who want medically supervised treatment without the friction of navigating traditional endocrinology referrals or bariatric surgery pathways. Calibrate competes with Found, Ro, Noom Med, and WeightWatchers Clinic in the GLP-1 telehealth market, differentiating through the depth of its structured year-long program and its coaching curriculum relative to prescribe-only telehealth competitors. ## Frequently Asked Questions ### Does Calibrate's program require taking GLP-1 medications, or can members participate without them? Calibrate's program is designed around medically supervised GLP-1 medication management as the primary intervention, though physicians assess each member individually. The coaching and curriculum components are structured to complement the medication rather than replace it. ### What does Calibrate metabolic health platform offer? Calibrate is a doctor-led metabolic health company that combines FDA-approved GLP-1 medications (such as Ozempic and Wegovy) with behavioral health coaching to help adults achieve sustainable weight loss and metabolic improvement. Its one-year program includes medical consultation, medication management, and ongoing lifestyle coaching. ### How is Calibrate priced? Calibrate charges a program fee for its one-year metabolic health program, with the cost of GLP-1 medications billed separately through insurance or out-of-pocket. The program fee covers medical consultations, health coaching, and the platform app. Pricing has varied and is listed on the Calibrate website. ### Who is Calibrate designed for? Calibrate serves adults with a BMI of 30 or above (or 27 with a weight-related health condition) who are seeking clinically supported weight loss with GLP-1 medications. It is intended for people who want medical oversight and behavioral coaching rather than medication alone. ### What is a GLP-1 medication and why does Calibrate use it? GLP-1 (glucagon-like peptide-1) receptor agonists like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) are FDA-approved medications that reduce appetite and improve metabolic function, resulting in significant and sustained weight loss when combined with lifestyle modifications. Calibrate uses these medications as a cornerstone of its evidence-based metabolic health program. ### How does Calibrate compare to Noom and Weight Watchers? Calibrate differentiates from behavior-only programs like Noom and Weight Watchers by incorporating FDA-approved GLP-1 medications prescribed and managed by doctors. This medical-plus-coaching approach produces significantly greater weight loss on average than behavioral programs alone. ### Does Calibrate accept insurance? Calibrate works to help members obtain insurance coverage for GLP-1 medications, as many commercial insurance plans now cover these drugs for obesity treatment. The program fee itself is not covered by insurance, but Calibrate provides tools to help members navigate medication coverage. ### What recent milestones has Calibrate achieved? Calibrate raised $100 million in Series B funding in 2021 and has navigated significant market changes as GLP-1 medications went from niche to mainstream. The company has refined its program structure and expanded its employer partnership channel as metabolic health has become a major benefit priority. ## Tags healthtech, saas, b2b, b2c, startup, platform, ai-powered, mobile-first --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*